Pioneer of genomics and synthetic biology. Led the Human Genome Project and founded 35+ biotech companies. His lab works on reversing aging at the genetic level.
10:00 – 10:40 AM | Multiplex Testing of De-aging Polypharmacy & Targeted Delivery
The Speakers
Pioneer of genomics and synthetic biology. Led the Human Genome Project and founded 35+ biotech companies. His lab works on reversing aging at the genetic level.
10:00 – 10:40 AM | Multiplex Testing of De-aging Polypharmacy & Targeted Delivery
Pioneered the landmark discovery that the adult human brain can generate new neurons, and paradigm-shifting research on brain plasticity, stem cells, and the brain as a genetic mosaic.
1:30 – 2:10 PM | In Vitro Models of Human Age-related Neurodegenerative Disease
Proved that human biological age is reversible through plasma dilution, reshaping the science of rejuvenation.
10:40 – 11:20 AM | Making Aging a Curable Disease
11:20 AM – 12:00 PM | One Generation: First Clinical Data from an Investigational Rejuvenation Therapy
Builds organ-on-a-chip systems that compress decades of human aging into days.
2:10 – 2:40 PM | Aging and Rejuvenation using Organ-on-a-Chip Systems
A leader in mitochondrial biology and evidence-based interventions for healthy longevity.
2:40 – 3:10 PM | Targeting Human Resilience and Healthspan
11:20 AM – 12:00 PM | One Generation: First Clinical Data from an Investigational Rejuvenation Therapy
11:20 AM – 12:00 PM | One Generation: First Clinical Data from an Investigational Rejuvenation Therapy
Serial founder pioneering clinically feasible organ replacement, carrying discoveries from the lab to the company.
3:55 – 4:25 PM | Engineering Integrated Organ Networks for Abundant Organ Replacement
4:25 – 4:55 PM | Microchip Platforms for Precision Molecular and Cellular Analysis
11:20 AM – 12:00 PM | One Generation: First Clinical Data from an Investigational Rejuvenation Therapy
Inventor of CRISPR-Gold and co-founder of GenEdit, engineering the delivery systems behind modern gene therapy.
3:10 – 3:40 PM | mRNA Delivery with Non-immunogenic Lipid Nanoparticles
One Generation
We will share research progress and company news as the programme develops.
Be an Insider